Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 9, 1997

View Archived Issues

Galderma develops novel compounds active on cell differentiation and proliferation

Pharmacia & Upjohn describes selective 5-HT2 antagonists

High-affinity inhibitor of biogenic amine transporters described

KGF receptor antagonists developed by U.S. researchers

Potential HIV-1 therapy disclosed by Houghten

Novel antitumor/immunomodulatory agents isolated by Japanese investigators

Keoprofen generic approval

FDA approves new HIV 1/2 test

Alendronate reduces occurrence of vertebral fractures in Fracture Intervention Trial

ISIS-2302 update

Study results reported for Genentech AIDS vaccine candidate

Ciclosporin bioequivalency established

ALRT announces new additions to the product pipeline

Gene discovery collaboration announced

Vion receives SBIR grant to develop ribonucleotide reductase inhibitor

Cariel trial initiated

GeneMedicine to begin phase I testing of IGF-I Gene Medicine

P&U files for European approval of urinary incontinence Rx

OXiGENE and Boston Medical Center announce collaboration

EchoGen submitted for European regulatory review

Orphan drug designation granted for NeuroCell-PD, NeuroCell-HD

Progress in Sugen's cancer development pipeline

Drug discovery collaboration agreement signed by Houghten, Chugai

Progenitor's functional genomics program advances

SKB/WRAIR malaria vaccine shown effective in clinical challenge trial

New insights into melanocortin role in obesity

ICOS-Suntory j.v. to develop rPAF-AH

CCD-1042 progresses in trials

VIMRxyn enters clinical testing in HCV-infected patients

QLT, AHP redefine Photofrin relationship

Three new melanoma vaccines from Therion Biologics enter clinical testing

Sequana and Glaxo Wellcome alliance

Company Profile: Epoch Pharmaceuticals

Protease inhibitor review published

Annual review of Ibex Technologies' product pipeline

AmBisome receives 25th approval/DaunoXome receives 17th approval

Positive phase III trial results reported for phosphate binder

Viracept now available to children

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...